Literature DB >> 32119600

Extracellular Vesicles of Stem Cells to Prevent BRONJ.

J Watanabe1, K Sakai1, Y Urata1, N Toyama1, E Nakamichi1, H Hibi1.   

Abstract

Extracellular vesicles (EVs), several tens to hundreds of nanometers in size, are vesicles secreted by cells for intercellular communication. EVs released from mesenchymal stem cells (MSC-EVs) have the potential to treat multiple diseases. This study aimed to determine the effects of MSC-EVs on bisphosphonate-related osteonecrosis of the jaw (BRONJ), whose pathogenesis and treatment are not yet established. To this end, zoledronic acid (ZOL) was administered to bone marrow cells and fibroblasts in vitro. In vivo, a BRONJ model was produced by administering ZOL to rats and extracting teeth. Each MSC-EV-treated and nontreated group was compared histologically and molecularly. In vitro, the nontreated group showed an increased number of β-galactosidase-positive cells and expression of senescence-associated genes p21, pRB and senescence-related inflammatory cytokines. Conversely, MSC-EV administration decreased the number of senescent cells and expression levels of p21, pRB and inflammatory cytokines. In vivo, in the nontreated group, the socket was partially uncovered by the oral epithelium, leaving an exposed bone. Conversely, in the MSC-EV-treated group, the socket was healed. Besides, in the nontreated group, β-galactosidase-positive cells existed in the socket and colocalized with the CD90 and periostin-positive cells. However, there were few β-galactosidase-positive cells in the MSC-EV-treated group. Furthermore, gene expression of stem cell markers Bmi1 and Hmga2 and the vascular endothelial marker VEGF was significantly increased in the MSC-EV-treated group, compared with that in the nontreated group. These results indicate that MSC-EVs prevent ZOL-induced senescence in stem cells, osteoblasts, and fibroblasts and reduce inflammatory cytokines. Furthermore, administration of MSC-EVs prevented senescence of cells involved in wound healing and the spread of chronic inflammation around senescent cells, thereby promoting angiogenesis and bone regeneration and preventing BRONJ.

Entities:  

Keywords:  bisphosphonate-associated osteonecrosis of the jaw; cellular senescence; exosomes; mesenchymal stem cells; wound healing; zoledronic acid

Mesh:

Substances:

Year:  2020        PMID: 32119600     DOI: 10.1177/0022034520906793

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  11 in total

1.  Harnessing biomolecules for bioinspired dental biomaterials.

Authors:  Nicholas G Fischer; Eliseu A Münchow; Candan Tamerler; Marco C Bottino; Conrado Aparicio
Journal:  J Mater Chem B       Date:  2020-08-04       Impact factor: 6.331

2.  Small Extracellular Vesicles Derived from Adipose Tissue Prevent Bisphosphonate-Related Osteonecrosis of the Jaw by Promoting Angiogenesis.

Authors:  Jiao Huang; Lin Wang; Weidong Tian
Journal:  Int J Nanomedicine       Date:  2021-05-07

Review 3.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

Review 4.  The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.

Authors:  Isabelle Corre; Franck Verrecchia; Vincent Crenn; Francoise Redini; Valérie Trichet
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

Review 5.  The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes.

Authors:  Amerigo Giudice; Alessandro Antonelli; Emanuela Chiarella; Francesco Baudi; Tullio Barni; Anna Di Vito
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-25

6.  Human placenta mesenchymal stem cell-derived exosomes delay H2O2-induced aging in mouse cholangioids.

Authors:  Wenyi Chen; Jiaqi Zhu; Feiyan Lin; Yanping Xu; Bing Feng; Xudong Feng; Xinyu Sheng; Xiaowei Shi; Qiaoling Pan; Jinfeng Yang; Jiong Yu; Lanjuan Li; Hongcui Cao
Journal:  Stem Cell Res Ther       Date:  2021-03-22       Impact factor: 6.832

7.  Treatment of bisphosphonate induced osteonecrosis of jaw in rats using an angiogenesis factor (A-Heal) and ABMDO (Autologous Bone Marrow Derived Osteoblasts).

Authors:  Mir Sadat-Ali; Naif A AlMasoud; Tarek M Hegazi; Sadananda Acharya; Ahmed A Alsulaiman; Ayesha Ahmed; Methal I AlBayat
Journal:  Saudi Dent J       Date:  2021-12-23

8.  Pro-angiognetic and pro-osteogenic effects of human umbilical cord mesenchymal stem cell-derived exosomal miR-21-5p in osteonecrosis of the femoral head.

Authors:  Shanhong Fang; Zhaoliang Liu; Songye Wu; Xinjie Chen; Mengqiang You; Yongfeng Li; Fuhui Yang; Shuhuan Zhang; Yiqun Lai; Peiyao Liu; Weijiawen Jiang; Peng Chen
Journal:  Cell Death Discov       Date:  2022-04-25

Review 9.  Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Ran Yan; Ruixue Jiang; Longwei Hu; Yuwei Deng; Jin Wen; Xinquan Jiang
Journal:  Int J Oral Sci       Date:  2022-08-10       Impact factor: 24.897

Review 10.  Emerging role of exosomes in craniofacial and dental applications.

Authors:  Xin Xing; Shuang Han; Zhi Li; Zubing Li
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.